1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Mental Health Analysis & Statistics in the United States, July 2020

Mental Health Analysis & Statistics in the United States, July 2020

1-30 of about 900 reports

Diabetic Peripheral Neuropathy (DPN) - Epidemiology Forecast-2030

  • $ 3750
  • Jul 2020
  • 80 pages

‘Diabetic Peripheral Neuropathy (DPN) - Epidemiology Forecast-2030’ report deliver an in-depth understanding of the disease, historical & forecasted epidemiology trends of Diabetic Peripheral Neuropathy ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • Germany
  • United States

Spinal Muscular Atrophy Treatment Market Research Report by Type, by Treatment, by Route of Administration - United States Forecast to 2025 - Cumulative Impact of COVID-19

  • $ 1449
  • July 2020
  • 88 pages

Spinal Muscular Atrophy Treatment Market Research Report by Type (Type 1, Type 2, Type 3, and Type 4), by Treatment (Drug Therapy and Gene Replacement Therapy), by Route of Administration - United States ...

  • Mental Health
  • Neurological Disorder
  • United States
  • Market Size

Neuroprotection Market Research Report by Product, by Treatment, by Application - United States Forecast to 2025 - Cumulative Impact of COVID-19

  • $ 1449
  • July 2020
  • 82 pages

Neuroprotection Market Research Report by Product (Apoptosis Inhibitors, Free Anti-Inflammatory Agents, Glutamate Antagonists, Metal Ion Chelators, and Neurotrophic Factors), by Treatment (Alzheimer’s ...

  • Mental Health
  • United States
  • Forecast

Neuromodulation Market Research Report by Technology, by Application - United States Forecast to 2025 - Cumulative Impact of COVID-19

  • $ 1449
  • July 2020
  • 99 pages

Neuromodulation Market Research Report by Technology (Deep Brain Stimulation, Gastric Stimulation, Sacral Nerve Stimulation, Spinal Cord Stimulation, and Vagus Nerve Stimulation), by Application (Chronic ...

  • Mental Health
  • Pathology
  • United States
  • Forecast

Multiple Sclerosis Market Research Report by Treatment Modality, by Application - United States Forecast to 2025 - Cumulative Impact of COVID-19

  • $ 1449
  • July 2020
  • 89 pages

Multiple Sclerosis Market Research Report by Treatment Modality (Injectable Agents and Oral Agents), by Application (Hospital and Research) - United States Forecast to 2025 - Cumulative Impact of COVID-19 The ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • United States
  • Forecast

Diabetic Neuropathy Market Research Report by Treatment Type, by Disorder Type, by Distribution channel - United States Forecast to 2025 - Cumulative Impact of COVID-19

  • $ 1449
  • July 2020
  • 85 pages

Diabetic Neuropathy Market Research Report by Treatment Type (Drugs, Physiotherapy, and Radiotherapy), by Disorder Type (Autonomic Neuropathy, Focal Neuropathy, Peripheral Neuropathy, and Proximal Neuropathy), ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • United States
  • Market Size

Brain Biomarkers Market Research Report by Product, by Indication, by End-Users, by Application - United States Forecast to 2025 - Cumulative Impact of COVID-19

  • $ 1449
  • July 2020
  • 81 pages

Brain Biomarkers Market Research Report by Product (Biomarker Analyzers and Biomarker Test Kits), by Indication (Alzheimer’s disease & other dementias, Huntington’s disease, MND & ALS, Parkinson’s ...

  • Biomarker
  • Genomics Proteomics And Enabling Technology
  • Mental Health
  • United States
  • Market Size

Behavioural Health Market Research Report by Disorder, by Service - United States Forecast to 2025 - Cumulative Impact of COVID-19

  • $ 1449
  • July 2020
  • 80 pages

Behavioural Health Market Research Report by Disorder (Alcohol Use Disorders, Anxiety, Bipolar Disorders, Depression, and Eating Disorders), by Service (Emergency Mental Health Services, Home-based Treatment ...

  • Healthcare
  • Mental Health
  • United States
  • Forecast

Treatment-resistant depression (TRD) - Market Insights, Epidemiology, and Market Forecast - 2030

  • $ 6950
  • June 2020
  • 200 pages

‘Treatment-resistant depression (TRD) - Market Insights, Epidemiology, and Market Forecast - 2030’ report delivers an in-depth understanding of the Treatment-resistant depression (TRD), historical ...

  • Depression
  • Mental Health
  • Therapy
  • United States
  • Market Size

Treatment-resistant depression (TRD) - Epidemiology Forecast - 2030

  • $ 3750
  • June 2020
  • 100 pages

‘Treatment-resistant depression (TRD)– Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Treatment-resistant depression, historical and forecasted epidemiology in the ...

  • Depression
  • Mental Health
  • Pathology
  • Therapy
  • United States

Childhood Absence Epilepsy Treatment Market Research Report by Drug, by Disease Type - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • $ 3949
  • June 2020
  • 222 pages

Childhood Absence Epilepsy Treatment Market Research Report by Drug (Lamotrigine, Phase 2 Drugs, and Valproate), by Disease Type (Atypical Absence Seizures and Typical Absence Seizures) - Global Forecast ...

  • Mental Health
  • Neurological Disorder
  • United States
  • World
  • Market Size

Alzheimer’s Disease Drugs Market Research Report by Drug Class, by Distribution Channel - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • $ 3949
  • June 2020
  • 231 pages

Alzheimer’s Disease Drugs Market Research Report by Drug Class (Cholinergic, Combined Drug, and Memantine), by Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy) - Global ...

  • Dementia
  • Mental Health
  • United States
  • World
  • Market Size

Diabetic Neuropathy Market Research Report by Treatment Type, by Disorder Type, by Distribution channel - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • $ 3949
  • June 2020
  • 217 pages

Diabetic Neuropathy Market Research Report by Treatment Type (Drugs, Physiotherapy, and Radiotherapy), by Disorder Type (Autonomic Neuropathy, Focal Neuropathy, Peripheral Neuropathy, and Proximal Neuropathy), ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • United States
  • Market Size

Spinal Muscular Atrophy Treatment Market Research Report by Type, by Treatment, by Route of Administration - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • $ 3949
  • June 2020
  • 233 pages

Spinal Muscular Atrophy Treatment Market Research Report by Type (Type 1, Type 2, Type 3, and Type 4), by Treatment (Drug Therapy and Gene Replacement Therapy), by Route of Administration - Global Forecast ...

  • Mental Health
  • Neurological Disorder
  • Therapy
  • United States
  • Market Size

Orthostatic Hypotension Drugs Market Research Report by Product - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • $ 3949
  • June 2020
  • 213 pages

Orthostatic Hypotension Drugs Market Research Report by Product (Droxidopa, Fludrocortisone, Indomethacin, Midodrine Hydrochloride, and NSAIDs) - Global Forecast to 2025 - Cumulative Impact of COVID-19 The ...

  • Mental Health
  • Neurological Disorder
  • United States
  • World
  • Market Size

Multiple Sclerosis Market Research Report by Treatment Modality, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • $ 3949
  • June 2020
  • 228 pages

Multiple Sclerosis Market Research Report by Treatment Modality (Injectable Agents and Oral Agents), by Application (Hospital and Research) - Global Forecast to 2025 - Cumulative Impact of COVID-19 The ...

  • Mental Health
  • Neurological Disorder
  • United States
  • Forecast
  • Market Size

North America Neurostimulation Devices Market By Devices By Applications By Country, Industry Analysis and Forecast, 2020 - 2026

  • $ 1500
  • May 2020
  • 86 pages

The North America Neurostimulation Devices Market would witness market growth of 11.8% CAGR during the forecast period (2020-2026). Neuromodulation is an interesting topic that is an important part of ...

  • Mental Health
  • Pathology
  • North America
  • United States

Global Neurostimulation Devices Market By Devices By Applications By Region, Industry Analysis and Forecast, 2020 - 2026

  • $ 3600
  • May 2020
  • 205 pages

The Global Neurostimulation Devices Market size is expected to reach $10.5 billion by 2026, rising at a market growth of 12.5% CAGR during the forecast period. Neuromodulation is a process that uses an ...

  • Mental Health
  • United States

Muscular Dystrophy - Pipeline Review, H1 2020

  • $ 2000
  • May 2020
  • 250 pages

Muscular Dystrophy - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Muscular Dystrophy – Pipeline Review, H1 2020, provides an overview of the Muscula ...

  • Mental Health
  • Neurological Disorder
  • United States
  • Company
  • Product Initiative

Diabetic Neuropathy - Pipeline Review, H1 2020

  • $ 2000
  • May 2020
  • 135 pages

Diabetic Neuropathy - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Neuropathy – Pipeline Review, H1 2020, provides an overview of the Diabetic ...

  • Mental Health
  • Neurological Disorder
  • Pharmaceutical
  • United States
  • Product Initiative

Insomnia - Pipeline Review, H1 2020

  • $ 2000
  • May 2020
  • 158 pages

Insomnia - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Insomnia – Pipeline Review, H1 2020, provides an overview of the Insomnia (Central Nervous ...

  • Hospital
  • Mental Health
  • United States
  • Product Initiative
  • Eisai Co., Ltd.

Spinal Cord Injury - Pipeline Review, H1 2020

  • $ 2000
  • May 2020
  • 243 pages

Spinal Cord Injury - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Spinal Cord Injury – Pipeline Review, H1 2020, provides an overview of the Spinal ...

  • Mental Health
  • Neurological Disorder
  • United States
  • Product Initiative
  • Athersys, Inc.

Protein Kinase C Epsilon Type - Pipeline Review, H1 2020

  • $ 3500
  • May 2020
  • 58 pages

Protein Kinase C Epsilon Type - Pipeline Review, H1 2020 Summary According to the recently published report ’Protein Kinase C Epsilon Type – Pipeline Review, H1 2020’; Protein Kinase C Epsilon Type ...

  • Dementia
  • Mental Health
  • United States
  • Product Initiative
  • Neurotrope, Inc.

Glycogen Synthase Kinase 3 Beta - Pipeline Review, H1 2020

  • $ 3500
  • May 2020
  • 69 pages

Glycogen Synthase Kinase 3 Beta - Pipeline Review, H1 2020 Summary Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) – Glycogen synthase ...

  • Mental Health
  • Therapy
  • United States
  • Product Initiative
  • AMO Pharma

Alzheimer’s Disease: Global Drug Forecast and Market Analysis to 2028

  • $ 10995
  • May 2020
  • 218 pages

Alzheimer’s Disease: Global Drug Forecast and Market Analysis to 2028 Summary Alzheimer’s disease (AD) is a progressive neurodegenerative disease that is characterized by memory loss, cognitive impairment, ...

  • Mental Health
  • United States
  • Allergan plc
  • Biogen Idec Inc.
  • Eisai Co., Ltd.

Insulin Like Growth Factor I - Pipeline Review, H1 2020

  • $ 3500
  • May 2020
  • 52 pages

Insulin Like Growth Factor I - Pipeline Review, H1 2020 Summary According to the recently published report ’Insulin Like Growth Factor I – Pipeline Review, H1 2020’; Insulin Like Growth Factor I ...

  • Antimalarials
  • Mental Health
  • United States
  • Product Initiative
  • Genervon Biopharmaceuticals, LLC

Metabotropic Glutamate Receptor 3 - Pipeline Review, H1 2020

  • $ 3500
  • May 2020
  • 36 pages

Metabotropic Glutamate Receptor 3 - Pipeline Review, H1 2020 Summary Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) – Metabotropic glutamate receptor 3 is a G protein-coupled recepto ...

  • Mental Health
  • Psychotic Disorder
  • Therapy
  • United States
  • Product Initiative

Metabotropic Glutamate Receptor 5 - Pipeline Review, H1 2020

  • $ 3500
  • May 2020
  • 76 pages

Metabotropic Glutamate Receptor 5 - Pipeline Review, H1 2020 Summary According to the recently published report ’Metabotropic Glutamate Receptor 5 – Pipeline Review, H1 2020’; Metabotropic Glutamate ...

  • Mental Health
  • Psychotic Disorder
  • United States
  • Product Initiative
  • Addex Therapeutics Ltd

Dermatomyositis - Pipeline Review, H1 2020

  • $ 2000
  • May 2020
  • 123 pages

Dermatomyositis - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Dermatomyositis – Pipeline Review, H1 2020, provides an overview of the Dermatomyositis ...

  • Mental Health
  • Therapy
  • United States
  • Product Initiative
  • Corbus Pharmaceuticals Holdings, Inc.

Spinocerebellar Ataxia (SCA) - Pipeline Review, H1 2020

  • $ 2000
  • May 2020
  • 104 pages

Spinocerebellar Ataxia (SCA) - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Spinocerebellar Ataxia – Pipeline Review, H1 2020, provides an overview ...

  • Mental Health
  • Therapy
  • United States
  • Product Initiative
  • Biohaven

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on